SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-16-005516
Filing Date
2016-09-29
Accepted
2016-09-29 14:41:30
Documents
64
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q entiabio10q063016.htm 10-Q 720700
2 EX-31.1 ex31-1.htm EX-31.1 12277
3 EX-31.2 ex31-2.htm EX-31.2 11781
4 EX-32.1 ex32-1.htm EX-32.1 3652
5 EX-32.2 ex32-2.htm EX-32.2 3716
12 image0.jpg GRAPHIC 4902
  Complete submission text file 0001185185-16-005516.txt   4190718

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ergo-20160630.xml EX-101.INS 830702
7 XBRL TAXONOMY EXTENSION SCHEMA ergo-20160630.xsd EX-101.SCH 49194
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ergo-20160630_cal.xml EX-101.CAL 30648
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ergo-20160630_def.xml EX-101.DEF 253919
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ergo-20160630_lab.xml EX-101.LAB 323304
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ergo-20160630_pre.xml EX-101.PRE 254179
Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 971-228-0709
Entia Biosciences, Inc. (Filer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52864 | Film No.: 161909672
SIC: 2833 Medicinal Chemicals & Botanical Products